Aussie-wide immunotherapy program launched for infants with peanut allergy
Dr Tim Brettig says oral immunotherapy will improve children's chances of safely eating the food allergen.
Free oral immunotherapy will be offered to infants with peanut allergy nationwide under the first Australian treatment program of its kind outside of a clinical trial.
As part of the ADAPT oral immunotherapy (OIT) program, eligible children under 12 months will receive a daily dosing schedule with small but increasing doses of peanut powder to build allergen tolerance over a two-year period.
